http://rdf.ncbi.nlm.nih.gov/pubchem/patent/AR-026797-A1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_d32a49211015b18ecef5a3a5195bf06e |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-7061 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-22 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-70 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-22 |
| filingDate | 2001-01-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2003-02-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | AR-026797-A1 |
| titleOfInvention | PHARMACEUTICAL COMPOUND WITH A PERMEATION PROMOTING ADDITIVE FOR THE TRANSDERMAL HORMONE ADMINISTRATION. |
| abstract | A pharmaceutical compound for the transdermal administration of one or more hormones, by adhesive contact fixation on the skin, with at least one matrix layer containing hormones containing at least one cutaneous permeability promoting additive, characterized by presenting said additive a structure basic 1,4-dioxane-2,5-dione of generic formula wherein the radicals R1 and R2 are hydrocarbon groups or substituted hydrocarbon groups or functional groups. |
| priorityDate | 2000-01-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
| Predicate | Subject |
|---|---|
| isDiscussedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID65432 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID415732526 |
Total number of triples: 14.